SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.29 |
Enterprise Value ($M) | 2.49 |
Book Value ($M) | -0.81 |
Book Value / Share | -0.39 |
Price / Book | -4.04 |
NCAV ($M) | -0.81 |
NCAV / Share | -0.39 |
Price / NCAV | -4.04 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -1.40 |
Return on Equity (ROE) | -1.77 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.67 |
Current Ratio | 0.67 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1.66 |
Assets | 1.66 |
Liabilities | 2.48 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -12.43 |
Net Income | -12.20 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -10.90 |
Cash from Investing | 0.00 |
Cash from Financing | 3.53 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
15,692 | 39,835 | 39.39 | |
1,798 | 6,060 | 29.67 | |
26,699 | 62,896 | 42.45 | |
10,202 | 57,985 | 17.59 | |
(click for more detail) |
Similar Companies | |
---|---|
TELO – Telomir Pharmaceuticals, Inc. | TENX – Tenax Therapeutics, Inc. |
TGTX – TG Therapeutics, Inc. | THTX – Theratechnologies Inc. |
TIL – Instil Bio, Inc. |
Financial data and stock pages provided by
Fintel.io